| Cash | 556.35K |
| Deferred financing costs | |
| Note receivable | |
| Interest receivable | |
| Prepaid expenses and other current assets | |
| Total current assets | 816.54K |
| Property and equipment, net | 22.97K |
| Patents and patents pending, net | |
| Deposits | 21.75K |
| Total assets | 950.84K |
| Accounts payable | 384.73K |
| Due to related parties | 58.36K |
| Notes payable | |
| Convertible notes payable, net of discounts | 605.82K |
| Derivative liabilities | |
| Accrued liquidated damages | |
| Other current liabilities | 35.32K |
| Total current liabilities | 1.08M |
| Commitments and Contingencies (Note 12) | 0 |
| Common stock, par value $0.001 per share; 250,000,000 shares authorized as of June 30, 2010 and March 31, 2011; 97,237,098 and 77,467,361 shares issued and outstanding as of June 30, 2011 and March 31, 2011, respectively | 7.71K |
| Additional paid-in capital | 90.81M |
| Deficit accumulated during development stage | |
| Total stockholders’ deficit | -67.63K |
| Total liabilities and stockholders' deficit | 950.84K |